Eli Lilly traded at $317.62 this Tuesday June 28th, decreasing $9.65 or 2.95 percent since the previous trading session. Looking back, over the last four weeks, Eli Lilly lost 1.33 percent. Over the last 12 months, its price rose by 38.48 percent. Looking ahead, we forecast Eli Lilly to be priced at 316.86 by the end of this quarter and at 291.97 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
317.62
Daily Change
-2.95%
Yearly
38.48%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 152.49 -0.65 -0.42% 35.79%
Abbott 106.97 -2.11 -1.93% -8.74%
ALKERMES 30.39 0.62 2.08% 25.06%
Amgen 243.51 -1.34 -0.55% 0.43%
AstraZeneca 10,786.00 -20.00 -0.19% 24.35%
Astrazeneca 65.93 -0.58 -0.87% 9.55%
Baxter International 65.25 -1.46 -2.19% -20.29%
Biogen 202.51 -11.06 -5.18% -41.42%
Bristol-Myers Squibb 78.70 -1.28 -1.60% 18.76%
Coherus Biosciences 7.35 -0.28 -3.67% -47.65%
Catalent 107.14 -3.73 -3.36% -1.84%
Endo International 0.71 0.33 85.33% -85.15%
Gilead Sciences 62.21 -0.62 -0.99% -9.66%
GlaxoSmithKline 1,766.00 1.80 0.10% 23.88%
Glaxosmithkline 43.35 -0.35 -0.80% 8.51%
Horizon Pharma 81.69 -3.80 -4.45% -13.88%
Intercept Pharmaceuticals 13.00 -0.48 -3.56% -38.36%
Jazz Pharmaceuticals 155.24 -1.45 -0.93% -13.29%
J&J 176.94 -5.18 -2.84% 7.87%
Lannett 0.59 -0.02 -3.28% -87.50%
Eli Lilly 317.62 -9.65 -2.95% 38.48%
Medtronic 89.20 -1.27 -1.40% -28.38%
Merck & Co 91.89 -2.52 -2.67% 19.01%
Neurocrine Biosciences 96.93 -3.00 -3.00% -0.01%
Novartis 81.14 -0.90 -1.10% -4.06%
Novartis 84.17 -1.11 -1.30% -8.34%
Phibro Animal Health 19.16 -0.14 -0.73% -33.59%
Prestige Brands 57.00 -1.12 -1.93% 9.30%
Pfizer 50.66 -1.22 -2.35% 29.57%
Perrigo 41.05 -0.52 -1.25% -11.07%
Drreddys Laboratories 55.29 -0.36 -0.65% -24.73%
Regeneron Pharmaceuticals 594.42 -7.98 -1.32% 8.87%
Roche Holding 317.55 -5.00 -1.55% -8.96%
Revance Therapeutics 14.55 -0.75 -4.90% -50.64%
Sanofi 99.37 -0.22 -0.22% 12.50%
Sanofi 52.14 -0.46 -0.87% -1.08%
Teva Pharmaceutical Industries 7.83 -0.38 -4.63% -21.93%
United Therapeutics 234.02 -7.12 -2.95% 32.21%
Zoetis 170.12 -3.48 -2.00% -9.51%

Indexes Price Day Year
US500 3831 -78.56 -2.01% -10.84%

Eli Lilly
Eli Lilly and Company is a drug manufacturing company. The Company discover, develop, manufacture, and market products in a human pharmaceutical product segment. The Company’s products include Diabetes and other endocrinology products, including Baqsimi, Basaglar, Forteo, Humalog, Humatrope, Humulin, Jardiance, Trajenta and Trulicity. Its Immunology products include Olumiant and Taltz. Its Neuroscience products include Cymbalta, Emgality, Reyvow, Strattera and Zyprexa. Its Oncology products include Alimta, Cyramza, Erbitux and Verzenio. Other product includes Cialis, for the tratment of erectile dysfunction and benign prostatic hyperplasia. The Company manufacture and distribute its products through facilities in the United States, Puerto Rico, and 8 other countries. Its products are sold in approximately 120 countries.